Literature DB >> 666290

Cefaclor: in vitro spectrum of activity and beta-lactamase stability.

H C Neu, K P Fu.   

Abstract

The in vitro activity of cefaclor against 556 clinical isolates of gram-positive and gram-negative bacteria was compared with that of other cephalosporins. Cefaclor had activity similar to that of cephalexin against gram-positive bacteria. It showed greater activity against Haemophilus strains than did cephalexin and inhibited beta-lactamase-producing Haemophilus isolates. Cefaclor was more active than cephalexin or cephalothin against Escherichia coli, Salmonella, and Shigella isolates but did not act against Serratia, Acinetobacter, indole-positive Proteus, or Bacteroides isolates. Cefaclor was resistant to type III (TEM) beta-lactamases but was destroyed by type I beta-lactamases and, to a lesser degree, by type IV and type V beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666290      PMCID: PMC352292          DOI: 10.1128/AAC.13.4.584

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Micro-iodometric assay for penicillinase.

Authors:  R P NOVICK
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

2.  Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.

Authors:  N J Bill; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

Review 3.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

4.  In vitro study of netilmicin compared with other aminoglycosides.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

6.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

  6 in total
  29 in total

1.  In vitro investigation of BK-218, a new oral and parenteral cephalosporin.

Authors:  I Szabó; J Barabás; A Tar; L Kiss; M Filep; T Schmidt; K Marossy; B Tóth-Martinez; G Barabás; F Hernádi
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and beta-lactamase-producing Haemophilus influenzae.

Authors:  E Yourassowsky; M P Van der Linden; F Crokaert
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

3.  [Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].

Authors:  A Bauernfeind; R Jungwirth; S Schweighart; M Theopold
Journal:  Infection       Date:  1990       Impact factor: 3.553

4.  In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin.

Authors:  A Tamura; R Okamoto; T Yoshida; H Yamamoto; S Kondo; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  Cefaclor: summary of clinical experience.

Authors:  R B Kammer; L J Short
Journal:  Infection       Date:  1979       Impact factor: 3.553

6.  In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.

Authors:  Y Utsui; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

7.  [In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)].

Authors:  I Braveny
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Cefaclor in the treatment of susceptible infections in infants and children.

Authors:  M J Spencer
Journal:  Infection       Date:  1979       Impact factor: 3.553

9.  Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.

Authors:  H Matsui; M Hiraoka; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 10.  Antibiotics for emerging pathogens.

Authors:  Michael A Fischbach; Christopher T Walsh
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.